Feasibility studies of the Pretest 2 phase of the German National Cohort- A nationwide study for health and frequent diseases in Germany
- Conditions
- Volunteers
- Registration Number
- DRKS00004291
- Lead Sponsor
- Helmholtz- Zentrum für Infektionsforschung
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Residents from the Hanover city and region who volunteer to participate in the study will be included.
Exclusion Criteria
Pregnant women and women who gave birth in the past 30 days will be excluded form the vaginal self-sampling study. Patients with arrythmias will be excluded from the Vasoscreen 3000 study.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Central functions (such as managing biosamples and quality control) to establish work flows, test and study their feasibilty.<br>2. To hire and train personel for the purpose of data collection and examining participants.<br>3. Testing various instruments/modules- testing various instruments for data collection and investigating their feasibility in a large population-based cohort study, to enable the best instruments to be chosen and and to modify existing instruments for the study.<br><br>
- Secondary Outcome Measures
Name Time Method